Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9231
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 251 $3,184,377 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $3,184,377 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 64% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency awarded a single-award Indefinite Delivery Contract (SPE2DR) valued at $499.999 billion to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, effective September 1, 2025, through December 31, 2036. This contract operates as a delivery vehicle under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. The contract is structured as a 30-month base period with three optional 30-month extension periods and authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables. DMS Pharmaceutical Group will serve as a critical regional supplier supporting military healthcare operations globally, with no set-aside designation applied, indicating the company competed in unrestricted federal procurement based on technical capability and price competitiveness.
Since the contract's award in September 2025, the Defense Logistics Agency has issued numerous delivery orders across diverse pharmaceutical categories, reflecting sustained demand for DMS Pharmaceutical Group's distribution capabilities. Representative delivery orders include high-value specialty pharmaceuticals such as Privigen 10% vials ($69,816), Perjeta 420 mg vials ($27,905.88), Xolair 150 mg/ml syringes ($15,792.20), and oncology treatments including Xtandi 40 mg capsules ($12,766.02); immunosuppressants and biologics including Nucala 100 mg/ml syringes ($19,318.30), Entyvio 300 mg vials ($19,522.72), and Nplate 500 mcg vials ($13,669.60); cosmetic and therapeutic injectables including Botox 200-unit vials (ranging from $16,504 to $23,105.60) and Exparel 266 mg/20 ml vials ($12,301.41); contraceptive devices including Mirena 52 mg and Kyleena 19.5 mg systems; and vaccines including YF-VAX yellow fever vaccine. All delivery orders utilize firm fixed-price pricing with no set-asides, with performance locations at DMS Pharmaceutical Group's headquarters in Park Ridge, Illinois, and completion dates ranging from December 2025 through January 2026, demonstrating the contractor's established performance capability in fulfilling the specialized and diverse pharmaceutical requirements essential to Department of Defense military medical operations.
Task orders
Show 40 more
Latest 50 of 251 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D9231?
SPE2DR25D9231 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D9231 worth?
Orders under SPE2DR25D9231 have obligated $3,184,377. SPE2DR25D9231's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9231?
251 orders have been placed under SPE2DR25D9231, the latest on July 29, 2026.
Who can order from contract SPE2DR25D9231?
SPE2DR25D9231 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9231 competed?
The extent of competition for SPE2DR25D9231 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV